Skip to main content
OpenTrials

Clinical trial condition

Type 2 Diabetes Mellitus

Explore clinical trials studying Type 2 Diabetes Mellitus. Study availability and eligibility vary by location and protocol.

1,509 public trials 41 recruiting studies
Refine in advanced search Browse all conditions

Type 2 Diabetes Mellitus trial results

Completed

Comparison of a New Formulation of Insulin Glargine With Lantus® Both in Combination With Oral Antihyperglycemic Drug(s) in Japanese Patients With Type 2 Diabetes Mellitus

NCT01689142

Conditions
Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +4 more
Locations
  • Investigational Site Number 392226 Amagasaki-Shi, Japan
  • Investigational Site Number 392218 Chigasaki-Shi, Japan
  • Investigational Site Number 392212 Chiyoda-Ku, Japan
  • Investigational Site Number 392208 Chuoh-Ku, Japan
View all 31 locations
View Trial Details
Completed

Fatty Acid Binding Protein 2 (FABP2) Ancillary Proposal

NCT00256633

Conditions
Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +4 more
Locations
  • Carl T. Hayden VA Medical Center Phoenix, Arizona, United States
  • Southern Arizona VA Health Care System, Tucson Tucson, Arizona, United States
  • VA Central California Health Care System, Fresno Fresno, California, United States
  • VA San Diego Healthcare System, San Diego San Diego, California, United States
View all 16 locations
View Trial Details
Completed

Markers and Mechanisms of Vascular Disease in Type II Diabetes

NCT00256646

Conditions
Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +4 more
Locations
  • Carl T. Hayden VA Medical Center Phoenix, Arizona, United States
  • Southern Arizona VA Health Care System, Tucson Tucson, Arizona, United States
  • VA Central California Health Care System, Fresno Fresno, California, United States
  • VA Medical Center, Long Beach Long Beach, California, United States
View all 17 locations
View Trial Details
Completed

Evaluation of the Blood Levels of the Drug (Lixisenatide), the Plasma Glucose Levels and Safety in Paediatric and Adult Patients With Type 2 Diabetes

NCT01572649

Conditions
Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +4 more
Locations
  • Investigational Site Number 840005 Chula Vista, California, United States
  • Investigational Site Number 840001 Overland Park, Kansas, United States
  • Investigational Site Number 840003 Louisville, Kentucky, United States
  • Investigational Site Number 484001 Puebla City, Mexico
View Trial Details
Completed

Efficacy and Safety of the Fixed Dose Combination of Glimepiride+Metformin in Type 2 Diabetic Patients Inadequately Controlled

NCT01699932

Conditions
Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +4 more
Locations
  • Investigational Site Number 422-002 Beirut, Lebanon
  • Investigational Site Number 422-001 Hazmiyeh, Lebanon
  • Investigational Site Number 643-03 Saint Petersburg, Russia
  • Investigational Site Number 643002 Saint Petersburg, Russia
View all 13 locations
View Trial Details
Completed

Evaluation of Fixed Dose Combination of Glimepiride and Metformin in Chinese Type 2 Diabetes Patients Inadequately Controlled With Metformin

NCT01457911

Conditions
Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +4 more
Locations
  • Investigational Site Number 156001 Beijing, China
  • Investigational Site Number 156016 Beijing, China
  • Investigational Site Number 156003 Beijing, China
  • Investigational Site Number 156018 Beijing, China
View all 22 locations
View Trial Details

Related conditions